Euro CBD market will grow; look for some shakeout globally
Despite significant institutional challenges, the European CBD market will see strong growth for those companies that can navigate the murky waters of EU regulation while…
Despite significant institutional challenges, the European CBD market will see strong growth for those companies that can navigate the murky waters of EU regulation while…
Insured patients in the USA would pay up to $200 per month for CBD-based drug Epidiolex under a recent pricing announcement from the maker, UK-based…
The monopoly on medical knowledge previously held by governments, pharma companies and the medical establishment has now been broken forever due to technological advancements and…
Health care needs to eschew a high-tech approach and go beyond the treatment of symptoms to attack the causes of chronic diseases rooted in current…
Recent approval of GW Pharmaceutical’s cannabidiol-based drug Epidiolex in the United States not only will soon give patients needed relief, but can spur further research…
EUROPEAN HEMP (Second of 4 parts) Part 1: Europe’s tough row to hoe: Lack of clarity on CBD, THC Upcoming: Part 3: Monday, July 2:…
Berlin-based MH medical hemp GmbH (MH) has applied for licenses to import and sell medical cannabis in German pharmacies, with approval expected this summer. MH…
Hemp activist Ras Chikomeni Chirwa says he may join Malawi’s presidential race next year as an independent candidate. While Chirwa, an elder in the Nyabinghi…
You need to login to view this content. Please Login. Not a Member? Join Us
Mumbai-based BOHECO has secured $1 million in financing from a group that includes Indian industrialist Ratan N Tata, You need to login to view the…